血管內(nèi)皮生長因子受體1(VEGFR1)多克隆抗體
Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Flt1; Fms-Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-like tyrosine kinase 1; Tyrosine-protein kinase receptor FLT
- 編號PAB818Ra01
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB818Ra01-血管內(nèi)皮生長因子受體1(VEGFR1)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種Homo sapiens (Human，人), Mus musculus (Mouse，小鼠)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 652 ¥ 1520 ¥ 2172 ¥ 5430 ¥ 21720
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
IHC圖
-
Figure. Western Blot; Sample: Recombinant VEGFR1, Rat.
-
Western Blot; Sample: Lane1: ECV304 cell lysate; Lane2: Human Placenta lysate
Primary Ab: 0.6μg/ml Rabbit Anti-Rat VEGFR1 Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Sample: Human 293T cell lysate;
Primary Ab: 1.5μg/ml Rabbit Anti-Rat VEGFR1 Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對VEGFR1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別VEGFR1。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB818Ra02 | 血管內(nèi)皮生長因子受體1(VEGFR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB818Ra01 | 血管內(nèi)皮生長因子受體1(VEGFR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB818Ra01 | 血管內(nèi)皮生長因子受體1(VEGFR1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB818Ra02 | 血管內(nèi)皮生長因子受體1(VEGFR1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB818Ra83 | 血管內(nèi)皮生長因子受體1(VEGFR1)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAB818Ra71 | 血管內(nèi)皮生長因子受體1(VEGFR1)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAB818Ra81 | 血管內(nèi)皮生長因子受體1(VEGFR1)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| MAB818Ra21 | 血管內(nèi)皮生長因子受體1(VEGFR1)單克隆抗體 | WB; IHC; ICC; IP. |
| LAB818Ra82 | 血管內(nèi)皮生長因子受體1(VEGFR1)單克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| SEB818Ra | 血管內(nèi)皮生長因子受體1(VEGFR1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB818Ra | 血管內(nèi)皮生長因子受體1(VEGFR1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Clinical cardiology | Growth Differentiation Factor 15 and Coronary Collateral Formation [PubMed: 20014173] |
| Microvascular Research | Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle [PubMed: 20937289] |
| Science Alert | Antiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats [Scialert: Source] |
| Acta Biomater | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study [PubMed: 26689470] |
| Naunyn Schmiedebergs Arch Pharmacol | The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis [PubMed: 26269412] |
| Acta Biomaterialia | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study [Pubmed:26689470] |
| Journal?of?Cellular?Physiology | A?Human?3D?In?Vitro?Model?to?Assess?the?Relationship?Between?Osteoporosis?and?Disseminationto?Bone?of?Breast?Cancer?Tumor?Cells. [pubmed:27925188] |
| Oncotarget | Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway. [pubmed:29262624] |
| Placenta | Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery. [pubmed:28962687] |
| Acta?Biomaterialia | Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment [Pubmed: 30445158] |
| Scientific Reports | Association between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea [Pubmed: 31882827] |
| JOURNAL OF DERMATOLOGICAL TREATMENT | Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris [Pubmed: 32043381] |
| FASEB JOURNAL | Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible?… [Pubmed: 33205477] |
| Children (Basel) | sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates [34438609] |
| Oxid Med Cell Longev | Reactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation [Pubmed:35693704] |
留言咨詢
